ILLUMENEAR AS
Operating
Leveranse av medisinsk utstyr og medisinske tjenester, samt det som
naturlig står i forbindelse med dette.
Utvikling og salg av medisinsk utstyr og medisinske tjenester, samt
det som naturlig står i forbindelse med dette.
Organization
- CEO
- MA
- Chairman of the board
- MA
- Years since formation
- 9 years
- since Jan 19, 2017
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Annual total result 2025
- -40,974
- NOK
- Total equity 2025
- -330,017
- NOK
Last update: Feb 24, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
MA | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
MA | Chairman | 100 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
MA | Managing Director/CEO, Chairman | 100 % directly |
Last update: Sep 30, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
MA | Ordinary shares | 100 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 50,000 | 0 |
Annual Total Result | -40,974 | -38,018 | -26,344 | 19,937 | -214,012 |
Total assets | 33 | 1,687 | 4,706 | 21,706 | 1,758 |
Total liabilities | 330,050 | 290,730 | 255,730 | 246,386 | 246,375 |
Total equity | -330,017 | -289,043 | -251,024 | -224,680 | -244,617 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 50,000 | 0 |
Total operating costs | 40,974 | 38,020 | 26,347 | 30,066 | 214,012 |
Operating result | -40,974 | -38,020 | -26,347 | 19,934 | -214,012 |
Financial income/costs | 0 | 2 | 3 | 3 | 0 |
Profit before tax | -40,974 | -38,018 | -26,344 | 19,937 | -214,012 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -40,974 | -38,018 | -26,344 | 19,937 | -214,012 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 | 0 |
Total current assets | 33 | 1,687 | 4,706 | 21,706 | 1,758 |
Total assets | 33 | 1,687 | 4,706 | 21,706 | 1,758 |
Short term debt | 330,050 | 290,730 | 255,730 | 246,386 | 246,375 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 330,050 | 290,730 | 255,730 | 246,386 | 246,375 |
Contributed capital | 24,430 | 24,430 | 24,430 | 24,430 | 24,430 |
Retained earnings | -354,447 | -313,473 | -275,454 | -249,110 | -269,047 |
Total equity | -330,017 | -289,043 | -251,024 | -224,680 | -244,617 |
Total equity and liabilities | 33 | 1,687 | 4,706 | 21,706 | 1,758 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification